When damage happens to neurons, glia are both the first responders and the long-term caregivers that orchestrate the steps to recovery. Recent reports reveal signals that control glial reactions to neuronal damage, provide insight into how these responses are turned off when the damage is repaired, and suggest new therapeutic interventions, including bone marrow transplantion and lithium treatment, to control the glial-neuron interface.
Revealing Draper's Secret Balancing Act
Glia are responsible for clearing up the toxic debris caused by neuronal injury that if left to accumulate might activate an inflammatory immune response or lead to the excitotoxic death of neighboring neurons. Logan et al. (2012) , working in the fruit fly, provide insight into how this process is activated or dialed down through the differential functions of two isoforms of the engulfment receptor Draper. These findings suggest that the canonical function for Draper in engulfment of damaged neurons is carried out by the Draper I splice isoform. By swapping the extracellular domain of Draper I with those of the other two isoforms, the authors show that it is the intracellular domain, which harbors an immunoreceptor tyrosine-based activation motif (ITAM), that mediates engulfment activity. Surprisingly, Draper II impedes engulfment and does so by negatively regulating Draper I through a mechanism that involves a previously unrecognized immunoreceptor tyrosine-based inhibitory motif (ITIM) and a preferential interaction with the tyrosine phosphatase Corkscrew. 
Raf Does Reparable Harm
Damage to peripheral nerves causes Schwann cells to enter a dedifferentiated state in which they are able to remove debris at the injury site, guide regrowing axons, and, when this process is completed, redifferentiate in order to carry out their normal role in axon myelination. Napoli et al. (2012) now show in a mouse model that the entry of Schwann cells into this dedifferentiated state can be controlled by Raf kinase activity. Previous work has shown that signals from the degenerating axons trigger the native dedifferentiation response. This latest work establishes in vivo a pathway in Schwann cells through which these signals are likely conveyed. The authors show that the specific activation of Raf/ERK signaling in Schwann cells (using an inducible transgene) is sufficient to trigger demyelination in the absence of neuronal damage, resulting in loss of motor function. It also recapitulates other features of damage-induced dedifferentiation, such as breakdown of the blood nerve barrier and stimulation of the inflammatory response, identifying a central role for Schwann cells in mediating this complex multicellular regenerative response. Once Raf activation is halted, remyelination occurs, restoring normal mobility. These features, and the fact that increased ERK signaling has previously been implicated in peripheral neuropathies, such as Charcot-Marie-Tooth and as a result of leprosy infection, make this model a compelling tool with which to study the disease process and assess potential interventions. Napoli, I., et al. (2012) . Neuron 73, [729] [730] [731] [732] [733] [734] [735] [736] [737] [738] [739] [740] [741] [742] 
Lithium Powers Remyelination
A new potential therapy for the treatment of peripheral nerve damage is suggested by recent work from Makoukji et al. (2012) , who show that lithium chloride (LiCl), the common antidepressant, stimulates remyelination in mice following injury. Using two peripheral nerve injury models (facial and sciatic nerve crush), they show that LiCl treatment enhances myelin gene expression, the extent of remyelination, and, in the case of the facial nerve injury, the speed of functional recovery of whisker movement (8 days versus 14 days for the placebo-treated group). A potential mechanism for this beneficial effect is examined in Schwann cell lines, where it is shown that LiCl inhibits its well-known target glycogen synthase kinase 3b (GSK 3b), which leads to the stabilization and nuclear accumulation of b-catenin. b-catenin then enhances the expression of peripheral myelin genes MPZ (encoding myelin protein zero) and PMP22 (encoding peripheral myelin protein 22) through its recruitment to TCF/LEF elements in the genes' promoters. From here, there are many possible next steps, among which the most tantalizing may be moving toward assessing whether LiCl could enhance peripheral remyelination in human trials. Makoukji, J., et al. (2012) . Proc. Natl. Acad. Sci. USA 109, [3973] [3974] [3975] [3976] [3977] [3978] Robert P. Kruger
Longitudinal section of the sciatic nerve of transgenic mice with enhanced Raf kinase activity (myelin protein P0, green; phospho-ERK, red).
Greater remyelination is observed following nerve crush in lithium-treated mice than in control mice. Image courtesy of C. Massaad.
